AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35554097 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg CU+
Number of subjects: 24
Study 35554097 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg CU+
Number of subjects: 24
Study 35554097 — intervention group
Group type: EXPERIMENTAL
Intervention: CU+
Number of subjects: 24
Study 35554097 — intervention group
Group type: COMPARATOR
Intervention: STE (1900 mg)
Number of subjects: 24
Study 32457071 — intervention group
Group type: EXPERIMENTAL
Intervention: Cabergoline (dopamine D2 receptor agonist)
Number of subjects: 0
Study 32457071 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study 35997834 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.017×0.025-inch stainless-steel archwire (group 1)
Number of subjects: 53
Study 35997834 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.019×0.025-inch stainless-steel archwire (group 2)
Number of subjects: 53
Study 35997834 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.021×0.025-inch β-titanium archwire (group 3)
Number of subjects: 53
Study 35997834 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 53
Study 35997834 — intervention group
Group type: EXPERIMENTAL
Intervention: Groups 2 and 3
Number of subjects: 53
Study 33933112 — intervention group
Group type: EXPERIMENTAL
Intervention: Early childhood education machine (uniform type) in addition to routine standard treatment and nursing
Number of subjects: 52
Study 33933112 — intervention group
Group type: COMPARATOR
Intervention: Routine standard treatment and nursing
Number of subjects: 52
Study 33933112 — intervention group
Group type: EXPERIMENTAL
Intervention: Early childhood education machine (uniform type)
Number of subjects: 52
Study 36402276 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile health application with relational agent
Number of subjects: 243
Study 36402276 — intervention group
Group type: COMPARATOR
Intervention: WebMD (control intervention)
Number of subjects: 243
Study 32830332 — intervention group
Group type: EXPERIMENTAL
Intervention: Polytherapy (Bright Light Therapy + Escitalopram Oxalate)
Number of subjects: 112
Study 32830332 — intervention group
Group type: COMPARATOR
Intervention: Monotherapy (Escitalopram Oxalate only)
Number of subjects: 112
Study 32830332 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments (Polytherapy and Monotherapy)
Number of subjects: 112
Study 32336721 — intervention group
Group type: EXPERIMENTAL
Intervention: Emerging new therapeutic strategies using proprotein convertase subtilisin‐kexin type 9 inhibitors or antisesnse oligonucleotide technology
Number of subjects: 0
Study 32336721 — intervention group
Group type: COMPARATOR
Intervention: Conventional pharmacological therapies (statin, niacin, cholesteryl ester transfer protein)
Number of subjects: 0
Study 35623543 — intervention group
Group type: EXPERIMENTAL
Intervention: PIPS activation with Irritrol
Number of subjects: 60
Study 35623543 — intervention group
Group type: EXPERIMENTAL
Intervention: PIPS activation with CHX
Number of subjects: 60
Study 35623543 — intervention group
Group type: COMPARATOR
Intervention: CI with Irritrol
Number of subjects: 60
Study 35623543 — intervention group
Group type: COMPARATOR
Intervention: CI with CHX
Number of subjects: 60
Study 35623543 — intervention group
Group type: COMPARATOR
Intervention: EDDY with Irritrol
Number of subjects: 60
Study 35623543 — intervention group
Group type: COMPARATOR
Intervention: EDDY with CHX
Number of subjects: 60
Study 33765997 — intervention group
Group type: EXPERIMENTAL
Intervention: Detectable viral load
Number of subjects: 328
Study 33765997 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-suppression of viral load (>1000 copies/mL)
Number of subjects: 328
Study 33765997 — intervention group
Group type: COMPARATOR
Intervention: Antiretroviral therapy of ≥1 year
Number of subjects: 328
Study 33765997 — intervention group
Group type: COMPARATOR
Intervention: Self-reported better adherence to antiretroviral drugs
Number of subjects: 328
Study 36303515 — intervention group
Group type: EXPERIMENTAL
Intervention: Midline catheter
Number of subjects: 143
Study 36303515 — intervention group
Group type: COMPARATOR
Intervention: Peripheral intravenous catheter
Number of subjects: 143
Study 36449291 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailed HPV self-sampling kit
Number of subjects: 19734
Study 36449291 — intervention group
Group type: COMPARATOR
Intervention: Usual care Papanicolaou screening reminders and outreach (Control)
Number of subjects: 19734
Study 33605836 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinnamon (3 g capsules)
Number of subjects: 160
Study 33605836 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 160
Study 35770587 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous Electrical Acupoint Stimulation (TEAS) at PC5 and PC6 acupoints
Number of subjects: 41
Study 35770587 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 41
Study 35770587 — intervention group
Group type: COMPARATOR
Intervention: Placebo (placebo intervention)
Number of subjects: 41
Study 32726531 — intervention group
Group type: EXPERIMENTAL
Intervention: TY014 (2 mg/kg)
Number of subjects: 37
Study 32726531 — intervention group
Group type: EXPERIMENTAL
Intervention: TY014 (20 mg/kg)
Number of subjects: 37
Study 32726531 — intervention group
Group type: EXPERIMENTAL
Intervention: TY014
Number of subjects: 37
Study 32726531 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 35777058 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mL of 2% mepivacaine (group M)
Number of subjects: 90
Study 35777058 — intervention group
Group type: COMPARATOR
Intervention: Saline (group S)
Number of subjects: 90
Study 35109589 — intervention group
Group type: EXPERIMENTAL
Intervention: Brain Health Champion (BHC) intervention
Number of subjects: 20
Study 35109589 — intervention group
Group type: COMPARATOR
Intervention: Counseling and Education (CE) control
Number of subjects: 20
Study 32797070 — intervention group
Group type: EXPERIMENTAL
Intervention: Observational-imitative method (OIM)
Number of subjects: 36
Study 32797070 — intervention group
Group type: COMPARATOR
Intervention: Descriptive-directive method (DDM)
Number of subjects: 36
Study 35016790 — intervention group
Group type: EXPERIMENTAL
Intervention: One-per-mil tumescent technique
Number of subjects: 35
Study 35016790 — intervention group
Group type: COMPARATOR
Intervention: Tourniquet
Number of subjects: 35
Study 33352040 — intervention group
Group type: EXPERIMENTAL
Intervention: Nd2(Ta0.2Sc0.2Sn0.2Hf0.2Zr0.2)2O7
Number of subjects: 0
Study 33352040 — intervention group
Group type: EXPERIMENTAL
Intervention: Nd2(Ti0.2Nb0.2Sn0.2Hf0.2Zr0.2)2O7+x
Number of subjects: 0
Study 35226769 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete Pulpotomy (CP)
Number of subjects: 106
Study 35226769 — intervention group
Group type: COMPARATOR
Intervention: Partial Pulpotomy (PP)
Number of subjects: 106
Study 33112463 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical herbal solution (MTS + THS)
Number of subjects: 24
Study 33112463 — intervention group
Group type: COMPARATOR
Intervention: 5% Minoxidil (MTS)
Number of subjects: 24
Study 35538731 — intervention group
Group type: EXPERIMENTAL
Intervention: High value incentives for providing a benzoylecgonine-negative urine sample
Number of subjects: 34
Study 35538731 — intervention group
Group type: EXPERIMENTAL
Intervention: Low value incentives for providing a benzoylecgonine-negative urine sample
Number of subjects: 34
Study 35538731 — intervention group
Group type: EXPERIMENTAL
Intervention: Escalating and resetting incentives
Number of subjects: 34
Study 35538731 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed incentives
Number of subjects: 34
Study 35538731 — intervention group
Group type: COMPARATOR
Intervention: Control condition receiving incentives for providing a urine sample regardless of results
Number of subjects: 34
Study 33229019 — intervention group
Group type: EXPERIMENTAL
Intervention: Life Goals Programme (LGP) - six weekly group sessions
Number of subjects: 64
Study 32907801 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapering TNF-inhibitor first
Number of subjects: 189
Study 32907801 — intervention group
Group type: COMPARATOR
Intervention: Tapering csDMARD first
Number of subjects: 189
Study 35751306 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal blanket
Number of subjects: 38
Study 35751306 — intervention group
Group type: COMPARATOR
Intervention: Incubator
Number of subjects: 38
Study 34600544 — intervention group
Group type: EXPERIMENTAL
Intervention: Artemether-lumefantrine (AL)
Number of subjects: 641
Study 34600544 — intervention group
Group type: EXPERIMENTAL
Intervention: Amodiaquine-artesunate (AS?AQ)
Number of subjects: 641
Study 35648432 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive Reflectance Confocal Microscopy (RCM)
Number of subjects: 3165
Study 35648432 — intervention group
Group type: COMPARATOR
Intervention: Standard therapeutic care (clinical and dermoscopy evaluation)
Number of subjects: 3165
Study 32580207 — intervention group
Group type: EXPERIMENTAL
Intervention: Long pulse width (LPW) stimulation
Number of subjects: 20
Study 32580207 — intervention group
Group type: EXPERIMENTAL
Intervention: Short pulse width (SPW) stimulation
Number of subjects: 20
Study 32580207 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline SCC CMRGlu
Number of subjects: 20
Study 32580207 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduction in SCC CMRGlu 6 months post DBS
Number of subjects: 20
Study 32580207 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine learning analysis
Number of subjects: 20
Study 32098536 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-lapse incubator (EmbryoScope™)
Number of subjects: 446
Study 32098536 — intervention group
Group type: COMPARATOR
Intervention: Conventional incubator (K‐System G‐185 Flatbed)
Number of subjects: 446
Study 33942350 — intervention group
Group type: EXPERIMENTAL
Intervention: Postdiagnosis aspirin use
Number of subjects: 2519
Study 33942350 — intervention group
Group type: EXPERIMENTAL
Intervention: Postdiagnosis aspirin use (≤ 1 maximum defined daily dose)
Number of subjects: 2519
Study 33942350 — intervention group
Group type: EXPERIMENTAL
Intervention: Postdiagnosis aspirin use (> 1 maximum defined daily dose)
Number of subjects: 2519
Study 33942350 — intervention group
Group type: COMPARATOR
Intervention: Nonusers of aspirin
Number of subjects: 2519
Study 32579773 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical platelet gel (PG)
Number of subjects: 60
Study 32579773 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) injection
Number of subjects: 60
Study 32579773 — intervention group
Group type: COMPARATOR
Intervention: Saline dressing and compression (Control)
Number of subjects: 60
Study 35046640 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (DEX) combined with Femoral Nerve Block (FNB)
Number of subjects: 88
Study 35046640 — intervention group
Group type: COMPARATOR
Intervention: Femoral Nerve Block (FNB) combined with Sciatic Nerve Block (SNB)
Number of subjects: 88
Study 33070479 — intervention group
Group type: EXPERIMENTAL
Intervention: MST (100 Hz applied over the vertex)
Number of subjects: 45
Study 33070479 — intervention group
Group type: COMPARATOR
Intervention: ECT (bifrontal)
Number of subjects: 45
Study 36049460 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitametik Impulse (VI)
Number of subjects: 135
Study 36049460 — intervention group
Group type: COMPARATOR
Intervention: Educational Program (EP)
Number of subjects: 135
Study 36049460 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined VI/EP group
Number of subjects: 135
Study 36049460 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 135
Study 33546013 — intervention group
Group type: EXPERIMENTAL
Intervention: ECMO combined with CRRT
Number of subjects: 0
Study 33546013 — intervention group
Group type: COMPARATOR
Intervention: ECMO
Number of subjects: 0
Study 32998324 — intervention group
Group type: EXPERIMENTAL
Intervention: Lutein (12 mg)
Number of subjects: 59
Study 32998324 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study 33292081 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical refrigerant spray (TRS)
Number of subjects: 300
Study 33292081 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 300
Study 35977444 — intervention group
Group type: EXPERIMENTAL
Intervention: Social stimuli (faces)
Number of subjects: 590
Study 35977444 — intervention group
Group type: COMPARATOR
Intervention: Non-social stimuli (shapes)
Number of subjects: 590
Study 33534895 — intervention group
Group type: EXPERIMENTAL
Intervention: Nolasiban 900 mg
Number of subjects: 1836
Study 33534895 — intervention group
Group type: EXPERIMENTAL
Intervention: Nolasiban 100 mg
Number of subjects: 1836
Study 33534895 — intervention group
Group type: EXPERIMENTAL
Intervention: Nolasiban 300 mg
Number of subjects: 1836
Study 33534895 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1836
Study 32738408 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive Health Check intervention in addition to the standard of care
Number of subjects: 0
Study 32738408 — intervention group
Group type: COMPARATOR
Intervention: Standard of care only
Number of subjects: 0
Study 35842289 — intervention group
Group type: EXPERIMENTAL
Intervention: Video Otoendoscopy (VO)
Number of subjects: 50
Study 35842289 — intervention group
Group type: COMPARATOR
Intervention: Standard Microscopy (SM)
Number of subjects: 50
Study 32875698 — intervention group
Group type: EXPERIMENTAL
Intervention: SPP muco‐periosteal flap
Number of subjects: 160
Study 32875698 — intervention group
Group type: COMPARATOR
Intervention: EPP mucosa flap
Number of subjects: 160
Study 32875698 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 160
Study 35367525 — intervention group
Group type: EXPERIMENTAL
Intervention: Trametinib (1.0, 1.5, and 2.0 mg daily for 28 days) plus whole brain radiation therapy (WBRT, 37.5 Gy/15 fractions)
Number of subjects: 10
Study 35367525 — intervention group
Group type: EXPERIMENTAL
Intervention: Trametinib plus WBRT
Number of subjects: 10
Study 32414637 — intervention group
Group type: EXPERIMENTAL
Intervention: Attitudes toward AI
Number of subjects: 123
Study 32587722 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia training (film with text, audio, and animation presented as a multimedia CD)
Number of subjects: 120
Study 32587722 — intervention group
Group type: COMPARATOR
Intervention: Lecture training (four one-hour training sessions)
Number of subjects: 120
Study 32587722 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimedia training
Number of subjects: 120
Study 32587722 — intervention group
Group type: COMPARATOR
Intervention: Lecture training
Number of subjects: 120
Study 36189534 — intervention group
Group type: EXPERIMENTAL
Intervention: Acacia nilotica paste
Number of subjects: 20
Study 36189534 — intervention group
Group type: COMPARATOR
Intervention: Povidone iodine solution
Number of subjects: 20
Study 33867382 — intervention group
Group type: EXPERIMENTAL
Intervention: Standing back extension exercise (fatigue-exercise group)
Number of subjects: 33
Study 33867382 — intervention group
Group type: COMPARATOR
Intervention: No exercise (fatigue-non-exercise group)
Number of subjects: 33
Study 33867382 — intervention group
Group type: COMPARATOR
Intervention: Standing back extension exercise without fatigue task (non-fatigue-exercise group)
Number of subjects: 33
Study 32562806 — intervention group
Group type: EXPERIMENTAL
Intervention: Image-and-text HWL
Number of subjects: 4134
Study 32562806 — intervention group
Group type: EXPERIMENTAL
Intervention: Image-and-text HWL with calories
Number of subjects: 4134
Study 32562806 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-only HWL
Number of subjects: 4134
Study 32562806 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-only HWL with calories
Number of subjects: 4134
Study 32562806 — intervention group
Group type: EXPERIMENTAL
Intervention: Calories only
Number of subjects: 4134
Study 32562806 — intervention group
Group type: COMPARATOR
Intervention: No label
Number of subjects: 4134
Study 36069869 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-source automated insulin delivery (AID) system
Number of subjects: 97
Study 36069869 — intervention group
Group type: COMPARATOR
Intervention: Sensor-augmented insulin pump (control)
Number of subjects: 97
Study 36115668 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy exercise rehabilitation with adherence support
Number of subjects: 116
Study 36115668 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy exercise rehabilitation alone
Number of subjects: 116
Study 32586437 — intervention group
Group type: EXPERIMENTAL
Intervention: CBIT (Comprehensive Behavioral Intervention for Tic Disorders)
Number of subjects: 15
Study 32586437 — intervention group
Group type: EXPERIMENTAL
Intervention: CBIT
Number of subjects: 15
Study 32335581 — intervention group
Group type: EXPERIMENTAL
Intervention: Blue LED light centered at 478 nm
Number of subjects: 98
Study 32335581 — intervention group
Group type: COMPARATOR
Intervention: Blue LED light centered at 459 nm
Number of subjects: 98
Study 33346789 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg/kg/day cannabidiol (CBD25)
Number of subjects: 224
Study 33346789 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg/kg/day cannabidiol (CBD50)
Number of subjects: 224
Study 33346789 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 224
Study 35473492 — intervention group
Group type: EXPERIMENTAL
Intervention: PWP-GT model with stratification by clusters
Number of subjects: 0
Study 35473492 — intervention group
Group type: EXPERIMENTAL
Intervention: PWP-TT model with stratification by clusters
Number of subjects: 0
Study 35473492 — intervention group
Group type: EXPERIMENTAL
Intervention: PWP-GT model
Number of subjects: 0
Study 35473492 — intervention group
Group type: EXPERIMENTAL
Intervention: AG model
Number of subjects: 0
Study 35473492 — intervention group
Group type: COMPARATOR
Intervention: Intervention condition
Number of subjects: 0
Study 34330461 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet + Physical Activity (PA)
Number of subjects: 46
Study 34330461 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet
Number of subjects: 46
Study 34330461 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 46
Study 32023931 — intervention group
Group type: EXPERIMENTAL
Intervention: Pan-fried (PF) beef steak sandwich
Number of subjects: 12
Study 32023931 — intervention group
Group type: EXPERIMENTAL
Intervention: Sous-vide (SV) beef steak sandwich
Number of subjects: 12
Study 32023931 — intervention group
Group type: COMPARATOR
Intervention: Both cooking methods (PF and SV)
Number of subjects: 12
Study 34167918 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-mA stimulation protocol
Number of subjects: 45
Study 34167918 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-mA stimulation protocol
Number of subjects: 45
Study 34167918 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 45
Study 36262979 — intervention group
Group type: EXPERIMENTAL
Intervention: Nursing humanistic care intervention (experimental group)
Number of subjects: 110
Study 36262979 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 110
Study 33836651 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadratus lumborum block (QLB)
Number of subjects: 64
Study 33836651 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 64
Study 33202147 — intervention group
Group type: COMPARATOR
Intervention: CPAP
Number of subjects: 317
Study 33202147 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAPflex
Number of subjects: 317
Study 32060880 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized Normative Feedback (PNF) intervention
Number of subjects: 760
Study 32060880 — intervention group
Group type: COMPARATOR
Intervention: No information (Control)
Number of subjects: 760
Study 33338269 — intervention group
Group type: EXPERIMENTAL
Intervention: Atrasentan 0.75 mg/day
Number of subjects: 3668
Study 33338269 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3668
Study 32517390 — intervention group
Group type: EXPERIMENTAL
Intervention: Suprascapular nerve pulsed radiofrequency (PRF) treatment
Number of subjects: 30
Study 32517390 — intervention group
Group type: COMPARATOR
Intervention: Suprascapular nerve block (NB) with lidocaine
Number of subjects: 30
Study 35598122 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) + Pyridoxamine di-hydrochloride (NP) (300mg NAC + 50mg pyridoxamine di-hydrochloride)
Number of subjects: 69
Study 35598122 — intervention group
Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) + Taurine (NT) (500 mg Taurine + 150 mg NAC)
Number of subjects: 69
Study 35598122 — intervention group
Group type: COMPARATOR
Intervention: Control (Placebo)
Number of subjects: 69
Study 33383999 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling, manual therapy, and exercise
Number of subjects: 77
Study 33383999 — intervention group
Group type: COMPARATOR
Intervention: Sham dry needling, manual therapy, and exercise
Number of subjects: 77
Study 33383999 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Dry needling and Sham)
Number of subjects: 77
Study 35104607 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal high-definition transcranial direct current stimulation (HD-tDCS) administered to the right inferior frontal gyrus (rIFG) for 5 consecutive days, twice a day.
Number of subjects: 40
Study 35104607 — intervention group
Group type: COMPARATOR
Intervention: Sham HD-tDCS administered to the right inferior frontal gyrus (rIFG) for 5 consecutive days, twice a day.
Number of subjects: 40
Study 34525239 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-use negative pressure wound therapy (s-NPWT)
Number of subjects: 95
Study 34525239 — intervention group
Group type: COMPARATOR
Intervention: Traditional negative pressure wound therapy (t-NPWT)
Number of subjects: 95
Study 35458108 — intervention group
Group type: EXPERIMENTAL
Intervention: DGA + POTATO (17.5 g/day resistant starch)
Number of subjects: 27
Study 35458108 — intervention group
Group type: COMPARATOR
Intervention: DGA + BAGEL (0 g/day resistant starch)
Number of subjects: 27
Study 34464517 — intervention group
Group type: EXPERIMENTAL
Intervention: BAY 1193397 (single oral doses of 0.5-50 mg)
Number of subjects: 0
Study 34464517 — intervention group
Group type: EXPERIMENTAL
Intervention: BAY 1193397 (single doses of 1 and 10 mg)
Number of subjects: 0
Study 34464517 — intervention group
Group type: EXPERIMENTAL
Intervention: BAY 1193397 (multiple doses of 2 and 5 mg twice daily and 10 and 20 mg once daily for 9 consecutive days)
Number of subjects: 0